Windlas Biotech Ltd Quarterly Results

Q4 FY25-26 Results Summary

Revenue

The revenue stands at ₹238.50 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.32 per cent from ₹233.10 crore. This corresponds to a year-on-year *(YoY) growth of 17.66 per cent.

Operating Profit

Operating Profit stands at ₹25.29 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.78 per cent from ₹24.37 crore. This corresponds to a year-on-year *(YoY) decline of 1.02 per cent.

PBDT

PBDT stands at ₹28.17 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.81 per cent from ₹27.67 crore. This corresponds to a year-on-year *(YoY) decline of 3.43 per cent.

Profit Before Tax

Profit Before Tax stands at ₹20.17 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.00 per cent from ₹19.97 crore. This corresponds to a year-on-year *(YoY) decline of 3.17 per cent.

Net Profit

Net Profit stands at ₹15.99 crore, reflecting a quarter-on-quarter *(QoQ) increase of 6.60 per cent from ₹15.00 crore. This represents a 1.78 per cent year-on-year *(YoY) decline for the same year.

YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Windlas Biotech Ltd News

Windlas Biotech Ltd Earnings

YOY

QOQ

Category	Q4 FY25-26	Q4 FY24-25	Change %	FY25-26	FY24-25	Change %
Total Revenue	238.50	202.71	17.66	904.09	759.88	18.98
Expenses	213.21	177.16	20.35	799.35	665.77	20.06
Other Income	4.35	4.94	-11.94	17.80	18.02	-1.22
Operating Profit	25.29	25.55	-1.02	122.55	112.13	9.29
Depreciation	8.00	8.34	-4.08	30.74	27.99	9.82
Interest	1.48	1.33	11.28	4.83	4.38	10.27
Profit Before Tax	20.17	20.83	-3.17	86.98	79.75	9.07
Tax	4.18	4.55	-8.13	20.72	18.29	13.29
Net Profit	15.99	16.28	-1.78	66.46	60.99	8.97

Category	Q1 FY26-27	Q1 FY25-26	Change %	FY25-26	FY24-25	Change %
Total Revenue	248.10	210.09	18.09	904.09	759.88	18.98
Expenses	221.42	183.57	20.62	799.39	665.76	20.07
Other Income	5.11	5.24	-2.48	17.80	17.65	0.85
Operating Profit	228.95	193.72	18.19	122.50	111.76	9.61
Depreciation	7.21	7.45	-3.22	30.74	27.99	9.82
Interest	1.65	1.06	55.66	4.83	4.38	10.27
Profit Before Tax	22.93	23.26	-1.42	86.94	79.39	9.51
Tax	5.28	5.59	-5.55	20.70	18.27	13.30
Net Profit	17.65	17.67	-0.11	66.44	60.65	9.55

Category	Q4 FY25-26	Q3 FY25-26	Change %
Total Revenue	238.50	233.10	2.32
Expenses	213.21	208.73	2.15
Other Income	4.35	4.57	-4.81
Operating Profit	25.29	24.37	3.78
Depreciation	8.00	7.70	3.90
Interest	1.48	1.28	15.62
Profit Before Tax	20.17	19.97	1.00
Tax	4.18	4.97	-15.90
Net Profit	15.99	15.00	6.60

Category	Q1 FY26-27	Q4 FY25-26	Change %
Total Revenue	248.10	238.50	4.03
Expenses	221.42	213.26	3.83
Other Income	5.11	4.40	16.14
Operating Profit	228.95	218.06	4.99
Depreciation	7.21	8.00	-9.88
Interest	1.65	1.48	11.49
Profit Before Tax	22.93	20.17	13.68
Tax	5.28	4.15	27.23
Net Profit	17.65	16.02	10.17

Windlas Biotech Ltd Research Reports

Action	Target Price (₹)	Broker	Date	Reports
Data Not Found

Windlas Biotech Ltd Financial Reports

Data not available.

Windlas Biotech Ltd Stock Prices Compare with Peers

Company	1 Day	1 Week	1 Month	3 Months	6 Month	1 Year
Windlas Biotech	-4.85%	-0.71%	-13.83%	1.01%	2.23%	-8.67%
Hester Bios	-0.29%	11.90%	9.22%	-5.81%	39.18%	40.93%
Indoco Remedies	-0.48%	-5.21%	-15.65%	-6.34%	-1.16%	-23.75%
Panacea Biotec	-4.21%	1.76%	-10.42%	-25.99%	-15.92%	-27.57%
Syncom Formul.	-5.78%	-3.89%	-16.74%	46.28%	39.59%	15.69%
Titan Biotech	-6.07%	8.13%	10.86%	1.97%	-14.38%	105.60%
Venus Remedies	-5.25%	-15.36%	-29.68%	-22.75%	25.85%	177.73%

Windlas Biotech Ltd Corporate Information

Chairman & Independent Directo: Vivek Dhariwal

WTD & Executive Director: ASHOK KUMAR WINDLASS

Joint MD & Executive Director: MANOJ KUMAR WINDLASS

Executive Director & MD: HITESH WINDLASS

Independent Non Exe. Director: Gaurav Gulati

Non Executive Director: Prachi Jain Windlass

Executive Director: Pawan Kumar Sharma

Independent Non Exe. Director: Tarashree Singhal

Company Sec. & Compli. Officer: Ananta Narayan Panda

Windlas Biotech Ltd News

Data Not Available